Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction

NCT02729233 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT02729233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02729233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Clinical Response to Golimumab With Mucosal Barrier Dysfunction
Lead sponsor
University of Arkansas
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2017
Completion date
January 27, 2017
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis